Streetbeat News

Stock Prices

CHSN

Chanson International's stock price is rising following the announcement of a $7.272 million public offering, involving 8,980,251 class A shares priced at $0.81 each.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:44 pm

CAN

GH

HYLN

ITOS

MRNO

MSTR

NVMI

SLDB

TIL

UPST

VZLA

Several US-listed stocks experienced significant declines in Monday's pre-market session. iTeos Therapeutics fell 13.7% after announcing interim data from a study. Upstart Holdings dropped 8.5% following a proposed convertible notes offering. Other notable decliners include Vizsla Silver, Murano Global Investments, Guardant Health, Hyliion Holdings, Instil Bio, Canaan, Solid Biosciences, Nova Ltd., and MicroStrategy.

Portfolio Pulse from Avi Kapoor

September 16, 2024 | 12:44 pm

MMSI

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced positive results from its WRAPSODY WAVE trial, showing superior patency in AV fistula patients compared to standard care. The trial demonstrated a 27% higher patency rate for WRAPSODY over percutaneous transluminal angioplasty.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:42 pm

GNLN

Greenlane shares rise following the launch of a new product line for fentanyl, xylazine, and drink spike detection test strips.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:42 pm

DCTH

Delcath Systems presented data at ESMO 2024 showing the efficacy of its HEPZATO KIT for treating metastatic uveal melanoma subgroups.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:38 pm

CLDX

Celldex Therapeutics announced that their Phase 2 study results for barzolvolimab in treating chronic spontaneous urticaria will be presented at the EADV Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:33 pm

COYA

Coya Therapeutics has announced that its subcutaneously administered COYA 302 has shown a direct anti-inflammatory effect in the brain in a preclinical inflammatory mouse model of Parkinson's Disease. This development could have implications for future treatments of neuroinflammatory conditions.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:30 pm

SUN

Sunoco LP (NYSE:SUN) shares rose slightly after JP Morgan raised its price target to $63. The company reported strong earnings and sales, beating analyst estimates. With a dividend yield of 6.55%, investors can earn $500 monthly by owning 1,713 shares. Dividend yields fluctuate with stock price changes.

Portfolio Pulse from Avi Kapoor

September 16, 2024 | 12:30 pm

SPY

The NY Empire State Manufacturing Index for September reported a significant increase to 11.5, surpassing the estimated -4.1. This unexpected rise indicates a stronger manufacturing sector in New York, which could positively influence market sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:30 pm

TIL

Instill Bio shares are trading lower following the announcement of their global registrational strategy for the PD-L1xVEGF bispecific antibody SYN-2510/IMM2510 in combination with chemotherapy for treating front-line non-small cell lung cancer and triple-negative breast cancer.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:22 pm